Showing results (71-80 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|September 12, 2024
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trialIrene J Higginson, Sarah T Brown, Adejoke O Oluyase, et al.
The Lancet. Respiratory Medicine|February 28, 2025
Perioperative lung expansion and pulmonary outcomes after open abdominal surgery versus usual care in the USA (PRIME-AIR): a multicentre, randomised, controlled, phase 3 trialAna Fernandez-Bustamante, Robert A Parker, Gyorgy Frendl, et al.
The Lancet. Respiratory Medicine|January 24, 2023
Effect of non-invasive ventilation after extubation in critically ill patients with obesity in France: a multicentre, unblinded, pragmatic randomised clinical trialAudrey De Jong, Anne Bignon, François Stephan, et al.
The Lancet. Respiratory Medicine|December 25, 2022
Understanding clinical and biological heterogeneity to advance precision medicine in paediatric acute respiratory distress syndromeMartin C J Kneyber, Robinder G Khemani, Anoopindar Bhalla, et al.
The Lancet. Respiratory Medicine|November 16, 2019
Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational studyDaniel J Wolter, Frankline M Onchiri, Julia Emerson, et al.
The Lancet. Respiratory Medicine|January 21, 2019
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trialMaria J Disselhorst, Josine Quispel-Janssen, Ferry Lalezari, et al.
The Lancet. Respiratory Medicine|July 10, 2021
Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists WorkshopMattia Arrigo, Susanna Price, David A Baran, et al.
The Lancet. Respiratory Medicine|July 16, 2021
Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelinesMatthew Jankowich, Bradley A Maron, Gaurav Choudhary
The Lancet. Respiratory Medicine|July 24, 2021
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trialKlaus F Rabe, Bartolome R Celli, Michael E Wechsler, et al.
The Lancet. Respiratory Medicine|July 12, 2021
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trialTimothy S C Hinks, Lucy Cureton, Ruth Knight, et al.
Pageof 103